Evaluation of the efficacy of imidacloprid 10 % / moxidectin 2.5 % (Advocate®, Advantage® Multi, Bayer) for the prevention of Dirofilaria repens infection in dogs. (Q52757108)
Jump to navigation
Jump to search
scientific article published in August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of the efficacy of imidacloprid 10 % / moxidectin 2.5 % (Advocate®, Advantage® Multi, Bayer) for the prevention of Dirofilaria repens infection in dogs. |
scientific article published in August 2013 |
Statements
Evaluation of the efficacy of imidacloprid 10 % / moxidectin 2.5 % (Advocate®, Advantage® Multi, Bayer) for the prevention of Dirofilaria repens infection in dogs. (English)
1 reference
1 reference
Claudio Genchi
1 reference
Marco Genchi
1 reference
Gabriele Petry
1 reference
Eva Maria Kruedewagen
1 reference
1 August 2013
1 reference
112 Suppl 1
1 reference
81-89
1 reference
Identifiers
1 reference